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11. BACKGROUND
Biologically programmed molecular recognition forms the basis for all complex natural
systems. Biology has therefore stimulated the use of self-assembly[a] (?bottom-up?)
approaches for the development of diverse biomimetic nanostructures,1 which are held
together by competing attractive and repulsive forces within a molecular system. DNA is
the nature?s very own predominant biopolymer for duplication and storage of genetic
information in biology, and makes a fascinating building block for self-assembled
structures and biotechnological research.2 DNA can be used even in applications that are
not immediately obvious, such as for building highly monodisperse nanostructures3, 4 and
DNA based computing.5-7 Compounds that bind DNA with high affinity are particularly
interesting for protecting DNA and ultimately delivering genetic material into cells; a
technique known as gene therapy.8 However, a single monovalent[b] binding unit can not
efficiently bind DNA under physiological conditions and to achieve high-affinity binding
multivalent ligands must be utilised. Dendrimers and dendrons are particularly interesting
binding agents because of their precisely defined branched structure with a high density of
functional surface groups, which can offer multiple simultaneous interactions leading to
enhanced binding ? the principle known as multivalency[c].9-12 Furthermore, dendrimers
can be designed in such a way that allows their self-assembly through supramolecular
interactions.13-15 Well-defined structures that are held together by non-covalent
interactions can be constructed principally in three ways from dendritic building blocks
(Figure 1):13
"We know nothing in reality, for truth lies
in an abyss."
- Democritus (c. 420 BC) -
1. Using templated or untemplated assembly through a functionalised focal point.
2. Employing noncovalent intermolecular dendron?dendron interactions can give rise
to the hierarchical assembly of nanostructured materials.
3. Dendron periphery with multiple surface groups can be functionalised in a desired
manner to invoke self-assembly and multivalent binding.16
Figure 1. Schematic illustration how dendron based structures are held together by non-
covalent interactions.13
[a] Term self-assembly is defined here as the spontaneous and reversible organization of molecular units
into ordered structures by non-covalent interactions.
[b] The International Union of Pure and Applied Chemistry (IUPAC) defines valence as: ?the maximum
number of univalent atoms that may combine with an atom of the element under consideration, or with a
fragment, or for which an atom of this element can be substituted.?
[c] In this Thesis term multivalent binding is used to describe the binding of two or more entities through
separate simultaneous interaction, between multiple (two or more) complementary ligand-receptor
functionalities on these entities, resulting in unique thermodynamic features termed as multivalency.
21.1. Gene Therapy
Gene therapy is defined as the use of genetic material to alleviate the symptoms of a
disease.8, 17 The principle is very simple: putting therapeutic gene into cells treats the
disease. Prospects of successful gene delivery range from slowing the growth of
tumours18-22 and progression of neurodegenerative diseases, such as Alzheimer?s and
Creutzfeldt-Jakob disease,23 to alleviating genetic diseases characterised by a single
mutation at a defined position on the genome, for example muscular dystrophy24 and
cystic fibrosis 25-27. However, several hurdles must be overcome before gene therapy can
be utilised to treat patients routinely. The key problems in gene therapy are: most
importantly, the lack of efficient delivery systems that could navigate DNA through cell
membranes and a series of extra- and intracellular barriers, lack of targeting to specific
tissue types, lack of long-term effects and strong immune response. The search for an
efficient delivery system, which could fulfil all the criteria for successful gene therapy, has
now been going on for several decades. The first clinical trial for gene therapy was carried
out in 1990 to treat severe combined immunodeficiency28 and since that several hundred
clinical trials have been pulled through. However, there is still no breakthrough to a
success story and the discovery of an ideal vector remains as a future challenge.
Nucleic acid used in gene therapy can be either double stranded DNA constructs or
single stranded systems, such as antisense oligonucleotides or short interfering RNA
(siRNA). Delivery of DNA with a gene coding for particular product commonly results in
the increased production of a therapeutic protein, whereas delivery of antisense constructs
will usually lead to a reduction of target activity. Although both of these approaches have
been extensively studied and the antisense approach has been regarded highly promising,
the following discussion will mainly focus on the delivery of DNA. To introduce genetic
material inside a cell, either ex vivo or in vivo transfer methods can be used. Ex vivo
method requires the removal, genetic modification and re-administration of patient?s cells.
In vivo method however is more interesting and involves either systemic or local delivery
of genetic material with for example injection. Current delivery vectors used in ex vivo
and in vivo methods can be divided into two complementary categories ? viral or nonviral
vectors.
Viral vectors employ a genetically modified virus particle to carry the wanted DNA
fragment inside them. Viruses, including for example retroviruses and adenoviruses, are
naturally evolved to efficiently deliver their own DNA into cells in a pathogenic manner.
Retroviruses are capable of integrating permanently within the host genome leading
possibly to sustained therapeutic effect. Adenoviruses however act transiently and do not
integrate in the host genome. Viral vectors that are used in gene therapy have all been
manipulated to remove disease-causing genes and insert therapeutic ones, but the
machinery which allows the virus to insert its genome into its host's genome is left
intact.29 Viral vectors can therefore deliver DNA with high efficiency and can possibly
mediate long-term expression.30 Neither are viral vectors troubled by one of the biggest
challenges in gene therapy, the targeting of delivery to specific cells: different viruses
show natural tropism to different tissues.31 However, viruses often induce an acute
immune response in their host, which has raised serious safety concerns to confront their
common use. Furthermore, viral vectors have a very limited capacity considering the size
of the molecule to be delivered. The risks of using viral vectors were unfortunately
realised in clinical trials involving engineered adenoviruses that resulted in patient?s death
due to a severe immune response32, 33 and reported findings of the risk of using engineered
3retrovirus vectors that may induce incorrect insertion of the therapeutic gene within the
regulatory or gene regions of a host genome leading to leukaemia.34-37
Nonviral methods employ their physical (carrier-free gene delivery) or chemical
(synthetic vector-based gene delivery) properties to aid gene transfer or pack DNA into a
form in which delivery becomes possible.38, 39 Physical approaches such as
electroporation,40 gene gun,41, 42 needle injection,43 hydrodynamic delivery44 and
ultrasound,45 utilise force to permeate cell membranes and facilitate gene transfer.
Chemical methods use synthetic or naturally occurring compounds (or their combination)
that bind DNA and allow the gene to cross the cell membrane (Figure 2). These vectors
can increase the efficiency of delivery and are usually not plagued by immune and
inflammatory response, but often exhibit low transfection efficiencies in medical
applications, especially in in vivo delivery. Also transient expression of the transgene is a
key problem that needs to be solved.
Figure 2. Simplified pathways of nonviral chemical gene delivery.46
Synthetic cationic systems rely on their ability to condense DNA into nanoscopic
particles, which can be taken up by cells via endocytosis and delivered into the nucleus,
where transgene expression can take place (Figure 2). Cationic lipids and cationic
polymers are the best-studied compounds for nonviral chemical gene therapy.46-49 Felgner
and co-workers first introduced cationic lipids (N-[1-(2,3-dioleyloxy)propyl]-N,N,N-
trimethylammonium chloride (DOTMA))50 in 1987 and only a year later appeared a key
study by Wu et al. who used a cationic polymer (poly-L-lysine) in gene transfer in vivo.51
The much-studied polyethylenimine (PEI) was introduced a few years later in mid 90?s by
Boussif et al.52 These landmark studies have since been flowed by numerous pioneering
studies and continue to stimulate the current research.
Cationic liposomes and cationic polymers are used in slight excess so that the resulting
DNA complexes have a cationic net charge that can interact electrostatically with
mammalian cells, which contain surface glycosaminoglycans and proteoglycans with
negatively charged chemical groups. During the endocytosis cationic lipids can
spontaneously mix with the endocytic vesicles to directly increase membrane fluidity and
promote release or disrupt endosome and prevent endosome maturation to lysosome,
4which quickly degrades it cargo.53 Cationic polymers however promote escape from
lysosomes with a different mechanism. For example, a portion of PEI?s amine nitrogen
atoms can be protonated during endosome maturation when its pH drops below 6.0 and
consequently the polymer can act as a proton sponge and offer buffering capacity to the
lysosome. PEI can therefore protect DNA from nuclease degradation and, with the
protons, bring chloride ions into the endosome, raising the osmotic pressure and cause
lysosomal swelling and consequent rupture that can provide escape for the PEI-DNA
complexes.52, 54 However, there are various features in the transfection procedure that can,
individually or in concert, affect the transfection efficiency. These include; the chemical
structure of the transfection agent, charge ratio (the nominal number of positive charges of
the polycation divided by the nominal number of negative charges present on the DNA),
size and structure of the resulting lipoplexes or polyplexes, the cell line and the total
amount of applied lipoplex or polyplex. These factors determine their structural
morphology and net charge, which directly affect the toxicity and transfection efficiency
of the procedure towards certain cells.
The importance of structural features was realised by Safinya and co-workers who have
extensively studied the relationship between structural morphology of cationic lipid-DNA
complexes and transfection efficiency in mammalian cells. The structural morphology of
lipoplexes can be diverse and three structures have been identified: lamellar L C phase,55,
56 with alternating lipid bilayers and DNA monolayers, an inverse hexagonal HIIC phase,57
where DNA is encapsulated within inverse micellar tubules, and hexagonally arranged HIC
phase,58 where tubular lipid micelles are surrounded by DNA rods forming a three-
dimensionally continuous substructure with honeycomb symmetry (Figure 3). However,
these structures can have very different effects on transfection efficiency, for example
efficiency of the inverted hexagonal HIIC cationic liposome-DNA complexes is
independent of the membrane charge density, but for the lamellar L C complexes the data
can be interpreted to a model with strong dependency between efficiency and the
membrane charge density.59
Figure 3. Self-assembled liquid crystalline equilibrium phases of cationic liposome-DNA
complexes. L C phase with alternating lipid bilayer and DNA monolayer and HIIC phase with
inverse micelles arranged on a hexagonal lattice.55-57, 60
DNA binding and packing is therefore one of the key features for efficient transfection
with nonviral chemical methods and understanding the factors that affect the interactions
between DNA and the vector is an important prerequisite for their controlled
5manipulation. The ionic interaction between a protonated amine and the phosphate
backbone of DNA forms the basis for most synthetic DNA binding molecules used for
gene delivery. However, an individual binding unit with one pronated amine cannot
efficiently bind DNA under physiological conditions and to achieve high-affinity binding
larger ligands must be utilised. While the number of binding sites and size of the
molecules increase, also the binding event becomes more complex to understand and tune.
Therefore binding ligands that can avoid structural complexity and have a very precise
structure with relatively low molecular weight are easier to study and consequently have a
bigger chance to result in applications. Polyvalent interactions give rise to special
phenomena such as cooperativity and multivalency and the design of such binding
systems requires a detailed understanding of the delicate balance between binding entropy
and enthalpy.
1.2. Multivalency
Valence of an entity has been defined as the maximum number of the same kind of
separate interactions that it can form with another entity. Multivalent interactions can
therefore occur between a host and a guest both having two or more complementary
binding sites resulting in unique thermodynamic features commonly termed as
multivalency. Conceptually related terms cooperativity and chelate effect can differ from
multivalency, but are sometimes used in literature in inconsistent manner as a substitute
for multivalency due to anachronistic terminology. Cooperativity can be used to describe
systems which do not involve multivalency such as the influence of binding a guest at the
host's binding site A on the second binding step occurring at site B of the same host.
Perhaps the best known example of such cooperative system in biology is the binding of
oxygen to haemoglobin subunits61 where the binding strength of the second O2 molecule is
increased by the first one and the sum of both binding energies is higher than two times
the binding energy of the first guest ( ). Cooperativity can therefore
describe allosteric monovalent interactions that do not rely on multivalency and it can be
synergistic ( ), additive ( ) or interfering
( ). Chelate effects also refers to the enhanced binding of guests to
multivalent hosts, but is primarily used for small molecules (mainly metals and ions)
binding to multivalent, often cyclic, hosts. Chelate effect should consequently be thought
as subclass under multivalency, but not strictly related to binding of metal ions. A classic
example of chelate effect is the ability of bidentate ligands (ethylene diamine, 2,2?-
bipyridine) to form a more stable complex with transition metals than corresponding
monodentate ligands (ammonia, pyridine).
mono
(first)
poly
avg GG
monopoly
avg GG
monopoly
avg GG
monopoly
avg GG
Multivalent interactions are ubiquitous throughout biology and they play an important
role in many biological recognition events.16 To achieve effective binding, nature prefers
to use multivalent interactions rather than a very strong monovalent interaction. From an
evolutionary point of view this seems advantageous because it allows binding of new
emerging molecules by using existing interactions rather then constructing an entirely new
one and a more dynamic control of interactions. For example, if there is a rapid need for a
high-affinity interaction, it is quicker to multiply the existing interactions than to develop
entirely a new binding ligand. Multivalency also allows grading of biological responses or
signalling by employing signal cascades where strength of the signal can vary based on the
number of host-guest interactions, resulting in a range of possible signal strengths. This is
6a clear advantage since a single host-guest interaction can in principle offer only an ?on?
and ?off? type of control.
Multivalent interactions encountered in nature highlight the importance of multivalency
in many biological systems. Examples of such interactions include: viral and bacterial
adhesion on cell surfaces via glycoprotein recognition, cell-cell interactions between E-,
P,- L-selectins and sLex during extravasation,62, 63 binding of antibodies having multiple
receptor sites to antigens64, 65 and control of gene transcription by DNA binding.66, 67 Gene
expression in eukaryotes and prokaryotes is controlled primarily at the level of
transcription. Most genes in eukaryotes are silent unless the multisubunit protein
machinery required for transcription is specifically recruited to the TATA box at the start
site of the gene. This recruitment is achieved by using transcription factors that recognise
the promoter sequences, such as TATA box and additional upstream sequences, located on
the 5? side of the start site. Transcription factors bind their target DNA with high affinity
and sequence specificity and have an additional activation domain that aids the assembly
of the RNA polymerase to the transcription complex. The DNA sequence to be recognised
is often conserved and the transcription factor that recognises it can be multivalent. An
example of this kind of behaviour is the gene regulation by oligomeric retinoid X receptor
(RXR), which is a member of nuclear hormone receptor superfamily proteins.68 RXR
consists of two domains, a binding domain and a ligand binding domain, and functions as
a transcription factor in the presence of its endogenous ligand (L), 9-cis retinoic acid.69
The DNA binding domain of RXR-ligand complex (RXR-L) recognises a single stranded
DNA cellular retinol-binding protein II element (CRBP-II). The striking feature of this
recognition is that the ensuing transcriptive response is highly sensitive to the
concentration of the transcription factor. This is because the transcription factor can
function as multivalent aggregate of ligands binding to a DNA sequence with multiple
binding sites. One to one binding affinity between a single RXR-L complex and a single
CRBP-II element is very low, however, the binding affinity increases for an interaction
between a (RXR-L)2 dimer and two adjacent elements (CRBP-II)2. An increase in the
binding affinity is further observed when tetramers are interacting and the clearly highest
affinity is between a pentamer complex (RXR-L)5 and five adjacent elements (CRBP-II)5
(Figure 4a). The result is that the rate of transcription is strongly activated by RXR-L
multimerisation ? a clear effect of multivalency.
7Figure 4. a) Binding of transcription factors to multiple sites on DNA: the binding
affinity of RXR-L complex towards CRBP-II element is increased when the number of
interacting subunits is increased.66 Top: monomers bind DNA with low affinity,
middle: dimers with higher, and bottom: pentamers with very high affinity. b) The
proposed binding mode of a dimeric -helical coiled coil leucine zipper protein to a
palindromic DNA sequence.70 Stabilising hydrophobic and van der Waals interactions
between leucine residues hold the two helices together so that they can bind to the
major groove of DNA.71 Dimerisation of the two chains is required for DNA binding.
Common DNA binding motifs that occur in transcription factors include zinc finger
and leucine zipper containing proteins that rely on multivalency to increase their DNA
binding affinity and specificity.70 Zinc finger relies on a  harpin-turn- helix motif
consisting of an elongated 30 residue unit, each containing two cysteines and two
histidines to coordinate a zinc ion.72 The zinc ion stabilises the structure and brings the
harpin and  helix in close proximity.73 Leucine zipper relies on similar strategy,
consisting of a stretch of close to 35 residues with a leucine at every seventh position
(Figure 4b). Leucine residues help to bring two leucine zipper proteins together by
stabilising the forming -helical coiled coil. Furthermore, the leucine zippers have an
approximately 30-residue long basic region at their amino-terminus, which serves as a
DNA binding module.71 Leucine zipper stabilised dimerisation is essential for achieving
DNA binding. In most cases the leucine zippers do not bind DNA as monomers and
dimerisation is required for the transcription factor to function.
An understanding of the structure and thermodynamics of multivalent systems is
needed for the design of synthetic multivalent molecules with desired properties. Also the
mechanism by which a multivalent molecule operates directly affects its potency and must
therefore be accounted. Multivalent molecules can affect biological processes principally
in two ways: by simultaneous binding to multiple receptor sites on biomolecules, thus
serving as inhibitors, or by receptor clustering, which is a key determinant to their
function as effectors.74 Different mechanisms by which a ligand can interact with a
receptor are presented in Figure 5. Monovalent ligands can commonly bind only to a
single site on the rector or heterodimerise a receptor via two receptor binding faces.
Mechanisms and topologies of multivalent interactions can, however, be more diverse:
8Chelate effect. Multivalent interactions in host-guest systems decrease their rate
of dissociation (koff), rather than increase the rate of association.
Subsite binding. Primary binding to the receptor also promotes secondary
binding interaction, which is in close proximity to the primary one.
Steric stabilisation. Binding of a large multivalent ligand inhibits further ligands
from binding by sterical blocking of the surface through the development of a
large gel-like layer.
Receptor clustering. Multivalent binding on receptors brings them to close
proximity thereby altering the signalling properties of the receptors.
Statistical effect. Multivalent ligands have a high local concentration of binding
units, which promotes rebinding.
Figure 5. Binding mechanism of mono- and multivalent ligands. Monovalent ligands:
a) single site binding b) receptor heterodimerisation. Multivalent ligands: a) chelate
effect b) subsite binding c) steric stabilization d) receptor clustering e) statistical
effects. 74
Binding between a ligand and a receptor can be expressed by the free energy of
interaction term ( ) between N ligands and N receptors.  can be split into
enthalpic ( ) and entropic ( ) components, of which the entropic term can
further be presented as a sum of changes in translational ( ), rotational ( )
and conformational ( ) entropies. Also the entropy of solvation ( )
describing the changes in the surrounding solvent molecules can be included.
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9The enthalpic term can either favour ( ) or disfavour ( )
binding. For example, the binding of a five subunit cholera toxin (AB
monopoly
avg HH
monopoly
avg HH
5) to its receptor,
GM1 oligosahharide moiety, is thought to be enhanced enthalpically,75 whereas
enthalpically diminished binding is encountered for example when multiple ligand
receptor interactions require energetically unfavourable molecular conformations.
and  are related to molecule?s freedom to move through space and rotate around
itself respectively. They are both logarithmically dependent on the molecular mass of the
molecule, however only translational entropy is dependent on the concentration where the
entropic cost increases with decreasing concentration ( S
poly
trans, NS
poly
rot, NS
trans ln([L])-1). Conformational
entropy  is associated with the physical arrangement of the multivalent molecule
that it assumes during binding. The framework that links the multiple binding ligands
together is generally flexible and does not match exactly the spacing between
corresponding receptors, therefore S
poly
conf,NS
conf  0. Interestingly, increasing the flexibility of
this linker results in increased conformational entropic cost of association, conversely the
same increase of flexibility decreases HN because all ligand-receptor interactions have a
smaller probability to occur with high energetic strain. Solvent interactions  are
particularly important for ions in water, as they provide the major driving force for ion
solvation. Also the release of water molecules that bind strongly together contribute to the
occurring interactions.
poly
solvent,NS
Investigating the thermodynamics of a multivalent system can be very challenging.
Kitov et al. have presented that the analysis of the thermodynamic parameters of
multivalent interactions with a multimeric receptor requires a special thermodynamic
model, which consisting of three elements: free binding energy of the initial single ligand-
receptor interaction, free binding energy of the other ligands in the same molecule on the
receptor and probability of association and dissociation of individual ligand branches.12
maxmax
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oGinter and are the two microscopic binding energies corresponding to the inter-
and intramolecular interactions. The first term corresponds to the free energy of the
first monovalent interaction  and is separated from the second term , which
subsequently describes the maximal number of additional intramolecular interactions (i
oGintra
oGinter
oGmono
oGintra
max
1), therefore  applies, where  represents the
free energy level of a degenerate state in ligand-receptor complex with i number of
interactions. A partial average over all bound states of the receptor gives the weight
coefficient probability w
i
ooo
i RTGiGG ln)1( intrainter
o
iG
i  of an individual ith bound level. The statistical term
 in equation (2) can be expressed in entropy units and has been
regarded as avidity entropy ( ), which is a measure of disorder in the distribution of
microscopically distinct complexes. The degeneracy of the bound states (
)/ln( iii wwR
oSavidity
i) is dependent
on the topology of the interactions and reflects an ensemble of microscopically
distinguishable ligand receptor complexes, rather than an individual ligand-receptor
molecule. G. Ercolani has drawn similar conclusions in his assessment of cooperativity in
self-assembly, where he also suggests that inter- and intramolecular processes should be
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considered as two distinct groups, although only virtually identical processes described by
equilibrium constants having the same dimensions should be compared.76 These type of
models can be used for the analysis of multivalent interactions and the prediction of
inhibition levels of multivalent receptor by a multivalent ligand as well as rational design
of multivalent compounds for desired purposes.74 Although elaborate efforts have been
made to understand multivalency, the strong increase of binding affinity is still not fully
understood in terms of enthalpy and entropy.
How to choose the best scaffold for multiple binding ligands? Different classes of
scaffolds include covalent frameworks such as low molecular weight compounds,
dendrimers and dendrons, globular proteins, linear polymers and polydisperse polymers.
Non-covalent frameworks include for example liposomes. Kiessling and co- workers have
studied the influence of multivalent ligand architecture (low molecular weight compounds,
polyamidoamine (PAMAM) dendrimers, bovine serum albumin protein, linear polymers
or polydisperse polymers) on the receptor-ligand binding mechanism.77 In this key study,
four different assays were used to assess the inhibitor and effector function of different
classes of multivalent compounds. Solid-phase binding assay was used to study binding
inhibition and quantitative precipitation, turbidity measurements and quenching of
fluorescence emission were used to investigate effector function. In general, low molucalr
weight compounds and globular proteins were observed to be poor inhibitors for binding
and poor effectors due to insufficient receptor clustering. Linear polymers and
polydisperse polymers were, however, much more effective inhibitors and effectors.
PAMAM dendrimers fall in between of these two groups in terms of their ability to cluster
receptors. Dendrimers and dendrons however posses other inherent advantages, such as
relatively low molecular weight, precisely defined structure, multivalent surface and the
possibility for easy structural variations thereby making them interesting scaffolds for
biological applications.
1.3. Dendrimers and Dendrons in Gene Therapy
Dendrimers are highly branched polymers exhibiting a symmetric monodisperse
treelike structure. A dendron, however, is an asymmetric half of a dendrimer. Both
dendrimers and dendrons consist of three main structural components (Figure 6):
Central core (C), the inner centre of
the molecule. Also referred to as the
focal point.
Figure 6. Structure of dendrimers and dendrons.
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Branched units are attached to the core in an iterative manner, to form layers called
?generations?. Each successive repeat unit along all branches forms the next generation of
growth: G1, G2, G3 and so on. There are two common approaches to dendrimer synthesis,
divergent and convergent. In the divergent approach branching monomers are introduced
one generation at a time, beginning from the core and ending at the periphery.78 However,
convergent synthesis begins from the outer surface shell of the target molecule and ends,
after an iterative synthetic procedure, at the central core.79 Both synthetic strategies
possess relative advantages and disadvantages and the method of choice always depends
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on the structure of the target molecules, the synthetic methods available for growth and the
specific synthons used in the construction of the dendritic framework.
The branched backbone can subsequently be functionalised with appropriate surface
groups, and indeed a very high density of functional groups is achievable due to the
branching structure. Therefore, the surface can be designed to have definite physical and
chemical properties. The exactly defined branched superstructure offers specific
advantages, for example a globular shape, radially controlled chemical structure, variable
inner volume and multivalent surface. Asymmetric dendrons have an additional
advantage; the central core can be substituted with desired functionality.
Dendrimers can also be prepared by a variety of self-assembly processes, such as,
supramolecular coordination chemistry or hydrogen bonding.15, 80 Coordination chemistry
is synthetically easy to access, and with appropriate choice of metals, can afford durable
structures. Dendritic structures can be prepared for example by using 2,3-bis(2-
pyridyl)pyrazines as bridging ligands, bipyridines as terminal ligands and Ru(II) or Os(II)
as coordinating metals (Figure 7a).81 These complexes exhibit extraordinarily large molar
absorption coefficients in the UV and visible spectral region. Furthermore, they contain
also a great number of redox-active centres, making these complexes applicable to
multielectron-transfer catalysts and photochemical molecular devices.
Hydrogen bond mediated self-assembly can also be utilised to form mesomolecular
dendritic assemblies with high stabilities and helical arrangement due to the bonding
strength and high degree of directionality. For example Zimmerman et al. prepared a
family of Fréchet-type dendrimers capable of assembly through the rigid tetracarboxylic
unit at the focal point (Figure 7b).82 More strikingly, the information programmed into
dendritic branches at molecular level controls directly the morphology of the formed
assembly ? a dendritic effect. Higher dendritic generation was found to increase the
stability of cyclic hexamer over linear aggregation (supramolecular polymer).
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Figure 7. a) Self-assembled heterometallic dendrimer.81 b) Isophtalic acid functionalised
dendron.82
A second way to utilise self-assembly is to use dendritic building blocks and their
dendron-dendron interactions to generate extended arrays through hierarchical self-
assembly. This kind of process usually leads to nanoscale structures in gel phase, such as
fibers and sheets, which also express their properties on a macroscopic scale, leading to
interesting materials properties.83 For example, fibrillar assemblies are recurrently found
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structures in nature, appearing with many kinds of functionalities and as part of complex
structures. Their research is of intense current interest because of their relevance in
neurodegenerative diseases, such as Alzheime??s and Creutzfeldt-Jakob diseases.23
Supramolecular fibers assembled from Fréchet-type dendrons with a dipeptide (Tyr-
Ala) focal point have been reported by Aida and co-workers. These structures rely on
well-organised complementary supramolecular interactions which give rise to a directional
assembly process (Figure 8).84 Higher generation dendritic branching was required for
effective gelation at low dendron concentration (1.0 mM). Detailed structural analysis
revealed fibrous nanostructure for some gelators while others showed 30-60 nm wide
nanoribbons (sheet structure). Interestingly, some of the gels indicated a helically twisted
hydrogen bonded arrays (fibers) in circular dichroism analysis.85
Figure 8. Proposed self-assembled structures of the dipeptide-core dendritic macromolecules.85
There has been enormous interest in using dendritic molecules or materials based upon
dendritic building blocks for biological applications.16, 86-94 Dendrimers and dendrons have
widely been used as multivalent scaffolds to organize manifold binding ligands for the
recognition of wide range different compounds, for example the multivalency principle in
the binding of saccharides to proteins on cell surfaces is now well established.11, 74, 95, 96 In
order to utilise dendrimers for energetically favourable binding interactions, they should
be designed in such a way where the number of binding interactions is maximised while
internal strain in the bound molecules is minimised. Both enthalpic and entropic factors
must be carefully considered because, enhanced binding energy of multisite attachment
must overcome the steric strain induced by the binding event. The high local concentration
of binding units and easy structural tunability of dendrimers can provide means to
investigate how different aspects of, for example, receptor clustering can be independently
influenced by multivalent ligand architecture. Dendrimers have been observed to rapidly
induce receptor clustering, although the orientation of the receptors was such that would
allow their function as effectors. This is probably due to the unfavourable distance and
orientation between receptors in the complex.77 These results demonstrate that not only the
binding ligands but also the multivalent ligand architecture contribute to the binding
modes and affinities. Although the principles underlying the multivalency principle can be
understood to some extent, a rational design of binding scaffold can be notoriously
difficult and efficient binding ligands are often discovered by sheer trial and error.
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Dendrimers are often used as DNA binding agents and consequently their ability to
transfect DNA has been widely studied.97, 98 DNA binding and packing is one of the key
features for efficient transfection. The interaction between a single protonated amine and
the phosphate backbone of DNA forms the basis for most DNA binding molecules.
Spherical polyamidoamine (PAMAM) dendrimers are relatively straightforward to
synthesise and have a positively charged polyamine surface and as a consequence they
have been studied extensively.99, 100 Increasing molecular weight of PAMAM dendrimers
has been found to amplify the transfection efficiencies. Indeed, a molecular weight greater
than 116 000 Da was determined to be optimal. Heat fracturing of dendrimer framework
results in a higher transfection efficiency, potentially as consequence of their greater
flexibility and ability to compact DNA.101 Attachment of polyethylene glycol (PEG) units
has been reported to enhance stability, transfection efficiency and circular half-life of
PAMAM dendrons.102, 103 Pegylated PAMAM dendrons also exhibited very low
cytotoxicities, although the overall transfection efficiency still remained low. In search for
better transfection agents also poly(propylene imine) 104 (PPI) and dendritic L-lysine105
have been studied. Park and co-workers took an interesting approach and combined a
linear polyethylene glycol and dendritic poly(L-lysine) to form a architectural co-
polymer.106 This novel block co-polymer could self-assemble with plasmid DNA at
physiological conditions, forming a compact and water-soluble polyionic complex. The
formed complex was studied by atomic force microscope (AFM) and found to take a
globular shape with a relatively narrow size distribution (see Figure 9). Nuclease
resistance and gel electrophoresis were used to confirm the binding and packing results.
Figure 9. a) Plasmid DNA and b) globular complexes formed between DNA and dendritic
poly(L-lysine) / PEG block co-polymer as studied by AFM.106
With the aim of producing more programmable supramolecular architectures of defined
and controllable composition in space, Diederich and co-workers have reported rationally
designed amphiphilic Newkome-type dendrimers for gene delivery.107 Relying on the low
toxicity, geometric tunability, and ease of multiple functionalisation of cationic
dendrimers on the one hand and the classic self-assembly of amphiphilic molecules on the
other, they developed a set of molecular building blocks to prepare amphiphilic
dendrimers. The rational design led to structures with rigid cores, high cationic charge
density on one side of the dendrimer surface and alkyl tails on the other (Figure 10).
Indeed, these amphiphilic dendrimers were found to have very high transfection
efficiencies, which were directly modulated by the size and number of alkyl tails and
cationic groups in the dendrimer. Transfection efficiency of these compounds even
exceeded that of SuperfectTM, which is an efficient commercial transfection agent.
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Figure 10. A tailored self-assembling amphiphilic dendrimer for efficient gene transfection.107
All of the above mentioned examples rely on the DNA binding function of the dendritic
vector. However, since a simple DNA binding molecule will most likely fail in delivering
DNA to a specific site at specific time in vivo, also other ?smart? functionalities have been
incorporated in nonviral vectors in order to enhance transfection efficiency and targeting.
Gene delivery vectors with smart properties could allow real-time control of delivery or
the gene transfection in the body. These types of vectors are currently under intense
research and could open new important ways to develop the field. Strategies for making
smart dendritic vectors with desired functionalities include principally two approaches:
targeting vectors by using cell-surface receptors and release of DNA using light or other
external stimulus. However, smart DNA delivery vectors based on dendritic molecules
remain largely unexplored.
Dendrimers that target DNA via receptor mediated endocytosis commonly consist of two
covalently liked segments:108 a segment that is a ligand for a cell surface receptor and a
cationic DNA binding segment (Figure 11). Upon mixing with DNA the ligands are
hypothesised to bind DNA and the targeting units remain exposed on the surface. The
ligand can be chosen to promote internalization via receptor mediated endocytosis to a cell
type that has the appropriate cell surface receptors to recognise the ligand.
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Figure 11. a) Structural design of a bifunctional multivalent dendron containing both
binding and targeting ligands. b) Bifunctional dendron with 15 surface amines and
three galactosyl residues used for efficient targeting of gene delivery to liver
hepatocytes.109, 110
Kim et al. have studied a series of bifunctional dendrimers consisting of a DNA
binding amine wedge and galactosyl functionalised wedge.109, 110 They concluded that a
15
dendrimer with 15 surface amines and three galactosyl residues was capable of delivering
DNA specifically to liver via asialoglycoprotein receptors on hepatocytes, being also the
optimal vector of the compounds studied. These types of dendritic vectors can be designed
in rational way to promote efficient DNA binding and target-specific gene delivery in
vivo.
Dendritic systems that can bind DNA and respond to external stimuli to control or
release DNA include azobenzene and phthalocyanine dendrimers. It was found that the
azobenzene dendrimer could respond to UV light and change its zeta potential and size. It
was further demonstrated that the DNA binding ability of the dendron was dependent on
its surface charge ? dendrimer with higher surface charge also had higher affinity towards
DNA.111 This is an important result since it shows that DNA binding affinity of a
dendrimer can directly be controlled by external stimulus. The first successful
photochemical-internalization-mediated gene delivery in vivo was published by Kataoka
and co-workers.112-114 They have developed a phototriggered system for in vivo DNA
delivery, in which the vector is composed of three components: a photosensitive anionic
phthalocyanine dendrimer (Figure 12a), which provides photosensitizing action, and DNA
packaged with cationic peptides which drives the third DNA payload towards the nucleus
of a cell after it has been released. Peptide-DNA polyplex can be released from the ternary
complex by laser irradiation at the visible wavelength, because laser irradiation on the
phthalocyanine dendrimer can induce photodamage to the endosomal membrane and thus
enhance endosomal escape (Figure 12b). Indeed, the in vitro transgene expression was
enhanced more than 100-fold by photochemical treatment and in vivo subconjuctival
injection of the ternary complex in an animal model showed transgene expression only in
the laser-irradiated site. This system presents the state-of-the-art in photochemical
enhancement of transgene expression by dendritic compounds.
a)       b)
Figure 12. a) Structure of the anionic phthalocyanine dendrimer. b) A schematic
presentation of the photochemical internalisation mediated gene delivery. Ternary
comples is designed to enter the cell by endocytosis. Phthalocyanine dendrimer can
induce selective photochemical damage to endosomal membrane.
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Other recent studies, although not based on dendritic molecules, have looked to the
development of functional DNA binding systems, which include quantum-dots,115
photosensitators116, nanoparticles117 or bioconjugates.118, 119 To achieve sufficient
transfection efficiencies and cell-specific targeting, protein?polymer conjugates
containing a cationic polymer such as polyethyleneimine (PEI) or poly(L-lysine) and an
immunoglobulin have been developed.120, 121 These conjugates rely on the ability of
cationic polymers to bind and to compact DNA, with the antibody being selected to
facilitate receptor-mediated gene delivery into various cell types.122 Thus, it is possible to
design very efficient conjugate vectors that possess distinct mechanisms to accomplish
DNA binding and cellular targeting.
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1.4. An Outline of the Thesis
The results presented in this thesis demonstrate that low-molecular-weight dendrons are
capable of high-affinity DNA binding in a generation dependent manner under
physiological salt conditions (article I) and are capable of modest gene delivery (article II).
Spatial and temporal control over the DNA binding was achieved by synthesising
dendrons in which the surface groups are attached via photolabile o-nitrobenzyl linker
(article III). Furthermore, it has been shown that these dendrons can be attached on larger
biomolecules and that their DNA binding ability is fully and directly transferred to other
nanoscale objects e.g. proteins (article IV and V). All these different approaches are
presented schematically in Figure 13.
Article I describes progress in optimising DNA binding and developing low molecular
mass dendrons with very high affinities for DNA ? such systems would be particularly
useful for DNA encapsulation and protection. We studied Newkome-type polyamine
dendrons, which have multivalent spermine arrays on their surfaces to increase the binding
efficiency. Such monodisperse systems enable an understanding of structure-activity
relationships, and additionally, have a greater chance of being licensed for therapeutic
applications in the longer term. In article II we studied the gene transfection properties of
these dendrons and found out that the dendrons transfect DNA only in the presence of
chloroquine, which promotes endosomal escape. The DNA binding affinity of these
dendrons might actually be too strong for efficient transfection and we therefore
developed systems where DNA can be released by external stimulus. In article III we
describe how light can be used to release DNA from dendrons by degrading and charge
switching multivalency. DNA binding compounds that can be manipulated by light are
especially interesting in eye targeted non-viral gene therapy. Article IV and V describe N-
maleimido cored dendrons that can be attached onto protein surfaces in site-specific
manner to yield exactly defined one-to-one protein-polymer conjugates, where the number
of dendrons and their attachment site on the protein surface is precisely known. As
suspected, the resulting protein-dendron conjugates bind DNA with high affinity. Further
studies in gene transfection, cytotoxicity and self-assembly establish relevance in gene
therapy as well as surface adhesion and patterning.
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2. HIGH-AFFINITY MULTIVALENT DNA BINDING BY
USING POLYAMINE DENDRONS
DNA constitutes a particularly interesting target for nanotechnological exploitation.
High affinity binding of DNA is useful for protecting DNA and ultimately delivering
genetic information into cells. Non-covalent interactions between dendritic
macromolecules and DNA are therefore of considerable current interest. In general, higher
generation, or structurally fractured, systems are usually more effective for DNA binding
and delivery. However, it would be advantageous to device low-molecular-weight
compounds capable of high-affinity DNA binding. Most dendrimers and dendrons are
utilised to bind DNA by using protonated amine surface groups that form ionic
interactions with the anionic phosphate backbone of DNA. The interaction between a
single protonated amine and a phosphate is relatively weak, and must compete with salt
binding under biological conditions. Biology therefore uses tetraamines, such as spermine,
to enhance and achieve DNA binding. Synthetic spermine derivatives are also widely used
for applications in DNA binding and delivery. However, although spermine is better than
an isolated amine for binding DNA, the interaction is still relatively weak, and
consequently, spermine struggles to compete with DNA-bound inorganic cations and loses
its DNA binding ability for example at higher salt concentrations.
In the following chapter it is demonstrated that the whole is more than the simple sum
of its parts. The synergistic multivalency effect of having multiple amine groups organised
onto single subunit can induce a binding affinity that is three orders of magnitude larger
when compared to individual binding units. However, even though the dendrons bind
DNA with extremely high affinity, the in-vitro gene transfection studies show only weak
transfection efficiency.
2.1. Low-Molecular-Weight Dendrons for DNA Binding (Article I)
This study presents multivalent dendritic spermine constructs with extremely high, salt
independent binding affinities for DNA. Synthesis of the target molecules was achieved
using divergent route, which was based on an efficient method to form orthogonally
protected second-generation dendrons, recently introduced by Cardona and Gawley.123
The dendritic moiety for all target molecules was chosen to be a biologically compatible
trifurcated Newkome-type ether dendrimer, based upon tris(hydroxymethyl)amine. This
framework is easy to synthesise and it allows minimisation of steric hindrance in the
second-generation dendrimer. The branches are also very flexible and therefore should
encourage complexation with DNA. This very same structure forms the basis of all the
dendrons presented in this Thesis. Focal point of the dendron was protected with a
benzyloxycarbonyl (Cbz) group, which is easy to remove enabling the attachment of
different functional groups. The synthetic flexibility provided by this latent reactive site at
the focal point is an inherent advantage of the dendron and provides vast potential for the
development of different DNA binding systems.
It was first necessary, however, to selectively protect the spermine to enable its clean
coupling to the periphery of the growing dendron. One of the primary amines of spermine
was regioselectively protected using the methodology of Blagbrough and Geall to give the
protected amine, which was subsequently reacted with an excess of t-butoxycarbonyl
(BOC) anhydride to protect the remaining amines.124 Treatment with conc. aq. ammonia
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yielded the asymmetrically BOC-protected spermine 1 (see the attachment at the end of
the thesis for graphical illustration, bold numbers refer to this scheme).
First and second generation Cbz?protected dendrimers G1, G2 and G0 model
compound (Figure 14) were efficiently and conveniently synthesised using carbodiimide-
hydroxybenzotriazole (DCC/HOBt) coupling chemistry and orthogonal protections.
Synthesis of the dendritic backbone began with 1,4-Michael addition of
tris(hydroxymethyl)aminomethane (Tris) to tert-butyl acrylate, producing the core
structure with the free amine 4. The primary amine was then reacted in good yield with
benzylchloroformate to afford Cbz-protected focal point (compound 5). Hydrolysis of t-
butyl protected acid groups of compound 4 with formic acid gave the tri-acid 6. Tri-acid 6
and protected spermine 1 were then coupled using standard DCC and HOBt peptide
coupling under basic conditions to provide fully protected first generation dendrimer 7.
The crude mixture was first purified with silica column in order to eliminate the excess of
DCC and HOBt. The residue was then concentrated and further purified with preparative
GPC to remove the side product dendron with only one or two branches. Deprotection of
the spermine BOC groups with HCl gas in methanol afforded target compound G1 in
quantitative yield. G0 model compound and its precursor 3 were constructed from
polyether 2 and protected spermine 1 with similar DCC/HOBt coupling and HCl
treatment. The approach followed for the synthesis of second generation target compound
G2 was based on the peptide coupling of 4 and 6 with DCC and HOBt. Deprotection of
the dendron periphery, the following functionalisation with spermine and its deprotection
were carried out as described for G1.
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Figure 14. Spermine and target spermine derivatives G0, G1 and G2.
Ethidium bromide displacement assay was utilised to study the binding of the spermine
derivatives to DNA. This assay measures the competition between the ligands and EthBr
for binding to DNA ? as EthBr is displaced by the ligands, its fluorescence, which is
enhanced when bound to DNA, decreases in intensity. The data obtained are presented in
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terms of C50 and CE50 values (Table 1). C50 values report the concentration of polyamine
causing a 50% decrease in fluorescence intensity. CE50 values represent the ?charge
excess?. Charge excess is defined as the nominal ?number of positive charges? of the
polyamine divided by the ?number of negative charges? present on the DNA.
At 9.4 mM NaCl concentration spermine binds to DNA with moderate strength (C50 =
1.33 M, CE50 = 5.3), but as the NaCl concentrations is increased to a physiological 150
mM level, spermine virtually loses its DNA binding ability (C50 = 390 M, CE50 = 1560).
Compound G0 showed similar, if slightly weaker, DNA binding. This was expected, as
one of the primary amines of spermine has been converted into an amide, which is
incapable of protonation, and G0 should therefore exhibit weaker electrostatic interaction
with polyanionic DNA.
Larger dendrons G1 and G2 with three and nine spermine units respectively showed
significantly enhanced DNA binding. G1 could efficiently bind DNA under low salt
conditions (C50 = 76 nM, CE50 = 0.68). Notably, the affinity for DNA is considerably more
than three times higher than that of G0. This indicates that the organisation of three
spermine units on the dendritic framework enables DNA binding activity that is more than
the simple sum of its individual parts ? the multivalency principle[3] in operation. When
the NaCl salt concentration is increased to 150 mM the binding affinity of G1 is somewhat
affected but still shows reasonable binding under these conditions (C50 = 300 nM, CE50 =
2.70).
G2 has similar DNA binding affinity as G1 at low salt concentration (C50 = 30 nM,
CE50 = 0.81), however the binding affinity of G2 is not altered by the increase in salt
concentration and the binding remains just as strong (C50 = 28 nM, CE50 = 0.76). The
binding is therefore salt independent ? a pro-active dendritic effect. The multivalent
system can therefore compete with Na+ cations for binding sites on the surface of the
DNA helix. Indeed, this proves that the strategy of organising spermine units into a well-
defined multivalent array has considerable power (Figure 15).
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Figure 15. Fluorescence titration profiles for the
addition of spermine, G0, G1 or G2 to a DNA
solution in buffered water (pH 7.2) in the presence of
150 mM NaCl.
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Table 1. Results for spermine, G0, G1, G2, HFBI, HFBI-G1 and HFBI-G2 from an ethidium
bromide displacement assay.[a]
Compound Molecularweight
Nominal
charge
CE50/9.4
mM NaCl
CE50/150
mM NaCl
spermine 202.3 4+ 5.3 >400
G0 363.3 3+ 60 >400
G1 1024.4 9+ 0.7 2.7
G2 3088.3 27+ 0.8 0.8
[a] Total added polyamine solution did not exceed 5% of the total volume; therefore corrections
were not made for sample dilution. Results are an average of three titrations.
DNA binding affinities were verified by gel retardation assay. Both spermine and the
G0 model compound failed to bind DNA and retard its migration, even at mass ratios of
1:100 (DNA:polyamine) (Figure 16). In contrast, dendritic spermine derivatives G1 and
G2 both effectively retarded the migration of DNA at mass ratios of 1:1 (DNA:polyamine)
and above. This highlights the cooperativity of the DNA binding afforded by using a
dendritic scaffold for the placement of multiple spermine groups, and also confirms the
results from the ethidium bromide displacement assay.
Figure 16. Agarose gel electrophoresis of polyamine/DNA complexes. (A) G0
(polyamine:DNA, w:w): lane 1, 0:1; lane 2, 6:1; lane 3, 7:1; lane 4, 8:1; lane 5, 9:1; lane 6,
10:1; lane 7, 20:1; lane 8, 30:1; lane 9, 40:1; lane 10, 50:1; lane 11, 60:1; lane 12, 70:1; lane 13,
80:1; lane 14, 90:1; lane 15, 100:1. (B and C) G1 and G2 respectively (polyamine:DNA, w:w):
lane 1, 0:1; lane 2, 0.1:1; lane 3, 0.2:1; lane 4, 0.3:1; lane 5, 0.4:1; lane 6, 0.5:1; lane 7, 0.6:1;
lane 8, 0.7:1; lane 9, 0.8:1; lane 10, 0.9:1; lane 11, 1:1; lane 12, 2:1; lane 13, 3:1; lane 14, 4:1;
lane 15, 5:1.
Transmission electron microscopy (TEM) was used to visualise the assembly of DNA-
dendrimer complexes (Figure 17). With spermine-DNA complexes (CE=1.8) large
unsymmetrical aggregates ca. 250 nm in diameter were observed. Compound G0,
however, led to little or no compaction of DNA under the same conditions. On the other
hand, G1 and G2 (CE 2.7) both condensed plasmid DNA into well-defined approximately
spherical nanoscale complexes (G1 ca. 100 nm, G2 ca. 400 nm) with no free plasmid
being detected. The size range of the aggregates formed was relatively large. Nonetheless,
these observations indicate that compounds G1 and G2 efficiently bind DNA and
condense it into spherical complexes.
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Figure 17. TEM images of DNA in the presence of (A) spermine (CE 1.8), (B) G1 (CE 2.7),
(C) G2 (CE 2.7) ? samples deposited from buffered water (pH 7.1).
In conclusion, we have presented first and second generation spermine functionalised
dendrons that bind DNA with remarkably high affinities. Notably, G2 showed salt-
independent DNA binding and it was considerably more efficient than the G1 under high-
salt conditions, whilst G1 was, in turn, significantly more effective than G0 analogue. It
can be further concluded that organised arrays of single binding units exhibit a clear effect
of multivalency when prearranged on a dendritic surface and yield a high affinity DNA
binding affinity that is more than the simple sum of the individual parts.
2.2. Potential as Nonviral Vectors in Gene Therapy (Article II)
In the last ten years, there has been an explosion of interest in using synthetic
molecules as vectors for gene delivery.8, 17 A range of materials such as cationic
liposomes,46, 48 polymers125, 126 and dendrimers127 have been utilized for this task.
However, they tend to be relatively inefficient in transfection and often lack cell specific
targeting. The transfection efficiency of dendrimers and dendrons is comparable to
polymers and cationic lipids.49, 128 In addition many of them are easy to modify with
various fuctional groups, for example with PEG groups to reduce toxicity. Spherical
PAMAM dendrimers have been studied the most because of their efficiency and
commercial availability.99 Other dendritic polyamine scaffolds have also been investigated
as gene delivery systems, such as those based on a poly(propyleneimine)104 (PPI) or
dendritic L-lysine105.
In article I we described how spermine functionalised dendrons bind DNA. This paper
elucidates the relationship of these dendrons between in vitro transfection efficiency and
toxicity. We investigated the ability of the dendrons to transfect DNA into cells (human
breast carcinoma cells, MDA-MB-231, and murine myoblast cells, C2C12) as determined
by the luciferase assay (Figure 18). Both cell lines were transfected in vitro with 1 µg of
plasmid DNA per 100,000 cells. In each case, the DNA was complexed with varying
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amounts of different polyamines. Gene transfection efficiency was measured as luciferase
enzyme activity and normalised to total cell protein. Initially, the dendrons were
investigated in their own right to determine their ability to transfect DNA into cells and
allow expression of luciferase. However, no measurable transfection could be observed in
any case.
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Figure 18. Transfection efficiency of spermine, the non-dendritic model (G0) and the
asymmetric dendrons displaying spermine on the surface (G1 and G2) in a) C2C12 and b)
MDA-MB-231 cells. Luciferase expression was normalised by total cellular protein. (N=6,
error bars represent standard deviation).
Chloroquine, a widely used ?helper molecule?, was therefore added (at a final
concentration of 100 µM) to aid the gene transfection. In the presence of chloroquine,
measurable gene transfection was observed with some of the spermine derivatives (Figure
18). At low polyamine:DNA mass ratios (1:1 and 4:1), the second generation dendron was
significantly better at transfection than the first generation analogue. However, at higher
polyamine:DNA mass ratios (10:1 and 20:1) the transfection efficiency of the second
generation dendron was observed to decrease sharply. Under equivalent conditions, the
transfection efficiency of the first generation analogue G1 increased dramatically. Indeed,
G1 became more effective at transfection than G2 at high polyamine:DNA mass ratios. A
similar trend was observed for both cell lines, although the transfection into murine
myoblasts C2C12 was higher than that for the human breast carcinoma cells (MDA-MB-
231). The non-dendritic molecules (i.e., spermine and G0) induced no measurable gene
expression over the range of polyamine:DNA mass ratios investigated (1:1 and 4:1).
One of the major drawbacks of administrating polycationic molecules to living cells is
that they have been reported to damage cell membranes as a result of the electrostatic
attraction of polycations to the plasma membrane, whereas neutral and anionic polymers
cause minimal damage to cellular membranes. We therefore assayed the cytotoxicity of
our dendrons using an assay based on the cleavage of 2,3-Bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) in metabolically active cells. The
same cell lines as used for transfection studies, human breast carcinoma cells (MDA-MB-
231) and murine myoblasts (C2C12), were exposed to various conditions (i.e., polyamine,
polyamine+DNA, polyamine+DNA+chloroquine) for 4 h, and metabolic activity was
assayed 20 h later. The results of these studies are collected in Table 2.
No reduction in metabolic activity was observed when the dendritic derivatives alone
were added at a concentration of 1 µg per 1000 cells. Only the 25 kDa
poly(ethyleneimine) (PEI) standard reduced the metabolic activity by 30% for the C2C12
cells, indicating that our dendrons are less cytotoxic than PEI. Similarly, when a
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combination of polyamine and DNA was added to the cells (0.2 µg DNA and 1 µg
polyamine per 1000 cells), our dendrons (G1 and G2) had no observable cytotoxicity.
However, once again, the 25 kDa PEI control reduced metabolic activity ? this time by
20% for the C2C12 cells.
Table 2. Cytotoxicity of spermine, the non dendritic model (G0), and first (G1) and second
(G2) generation dendrons, as well as PEI in murine myoblast C2C12 and human breast
carcinoma MDA-MB-231 cells. Cytotoxicity is reported as the effective metabolic activity,
using an XTT assay. In each case, the metabolic activity of a blank sample of cells (i.e.
untreated by polyamine, DNA or chloroquine) was taken as 1.000.
metabolic activity (relative to 1.000)
cell line conditions spermine G0 G1 G2 PEI CQ
C2C12 no polyamine 0.512
C2C12 polyamine alone 0.980 1.000 1.070 1.006 0.705
C2C12 polyamine + DNA 1.659 1.032 1.032 1.015 0.808
C2C12 polyamine + DNA + chloroquine 0.758 0.968 1.238 0.305
MDA-MB-231 no polyamine 0.678
MDA-MB-231 polyamine alone 1.022 1.070 1.003 0.997 0.878
MDA-MB-231 polyamine + DNA 1.099 1.063 1.011 1.034 0.954
MDA-MB-231 polyamine + DNA + chloroquine 0.886 0.979 0.988 0.398
a: CQ = chloroquine
Significant cytotoxicities, however, were observed in the presence of chloroquine,
under experimental conditions identical to those in which transfection had been performed
(i.e., 0.01 µg DNA and 0.1 µg polyamine per 1000 cells, and chloroquine at a final
concentration of 100 µM). Under these conditions, chloroquine and DNA reduced
metabolic activity by 50% (even in the absence of polyamines). In the presence of
chloroquine, DNA and either spermine, G0 or G1, the cells actually exhibited greater
metabolic activities than they did in the absence of the polyamine. Indeed, in the presence
of G0 or G1, the metabolic activity of the cells was effectively normal. However, using
chloroquine and DNA in the presence of G2 gave rise to a marked reduction in metabolic
activity (ca. 70% for C2C12 cells). In all cases, the MDA-MB-231 cells were found to be
more robust, and the polyamines and chloroquine were found to have smaller effects on
the metabolic activity than they do for C2C12 cells.
In summary, this paper investigated the ability of our new simple dendron structures,
functionalised on the surface with multiple spermine groups, to act as vectors in gene
therapy. The dendrons were unable to deliver DNA in vitro on their own right, however,
they were capable of transfecting DNA when administered with chloroquine, which assists
with escape from endocytic vesicles. Even in the presence of chloroquine the overall
transfection efficiency is very low when compared to commercial transfection agents, and
does not allow real applications. One of the possible reasons for low efficiency is that the
DNA binding affinity of the dendrons is in fact too strong and DNA is not released in the
extend needed for efficient transfection. The dendrons were non-toxic either alone, or in
the presence of DNA. Conversely, when administered with DNA and chloroquine, the
most highly branched dendron did exhibit varying cytotoxicity effects. It is clear that in
future studies the structure of the dendrons must be modified in such way to allow
efficient transfection without chloroquine. However, the current results provide
encouragement that this type of building blocks, which have a relatively high affinity for
DNA, will provide a useful starting point for the further synthetic development of more
effective gene transfection agents.
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2.3. Optically Switchable DNA Binding (Article III)
In this study we have modified our cationic multivalent dendrons presented in paper I,
by introducing an o-nitrobenzyl link129 between the spermine surface groups and the
dendron framework. Optical irradiation can be used to cleave the ester functionality of this
group from the dendritic scaffold, resulting in rapid release of the covalently bound
surface groups and non-covalently bound DNA, due to dendron degradation and charge
switching multivalency.
Controlling the self-assembly or function of nanoscale objects using external stimuli,
such as pH, temperature, light, electric potential, or magnetic field, is an important
requirement for the preparation of functional and responsive molecular machines for a
wide range of potential applications. 9, 10, 80, 130, 131 Special focus has been on medicinal
applications ? for example, controlled drug and DNA delivery systems,113, 132 reactivation
of caged enzymes,133 and switchable membrane proteins.134 Light as an external stimulus
enjoys a number of advantages, such as sharply defined spatiotemporal control over the
responsive effect, biocompatibility and easy usage. 113, 133 DNA binding compounds that
can be manipulated by light are especially interesting in DNA based computing,4, 6, 7??on-
chip? DNA storage5 and non-viral gene therapy,113, 114 because spatial and temporal control
over the release event can be gained. Most of the compounds used in gene therapy bind
DNA, however unpackaging of the complexes and release of the DNA is difficult to
achieve if the binding is very strong. This might be responsible for low transfection
efficiency, such as those results presented in publication II. DNA release is therefore of
direct importance.
Recent studies on photocleavable dendrimers and dendrons, include for example self-
immolative dendrimers135, porphyrin derivatives113 and dendrimers based on
photocleavable core136, 137 or photoactive surface.138, 139 Given our interest in multivalent
DNA recognition and transfection, we decided to explore whether our polyamine dendrons
could be developed in such a way as to achieve photoresponsivity. We therefore modified
our previously reported dendrons by attaching the spermine surface groups via an o-
nitrobenzyl link (Figure 19a). The o-nitrobenzyl group undergoes photolytic degradation
(Figure 19b) using long wavelength UV-light ( =350 nm), thus allowing spatially and
temporally controlled release of the covalently attached spermine surface groups and the
non-covalently bound DNA. Once the spermine groups are cleaved from the surface of the
dendron, the cationic multivalency effect is destroyed, leaving just individual spermine
groups, with only weak affinity for DNA. In this way, DNA will be effectively
decomplexed on photolysis. Importantly, as the surface groups are cleaved, they leave
behind an anionic carboxylic acid surface that will further repel DNA and thus promote
release (Figure 19c).
Polyamine dendrons with o-nitrobenzyl linked spermine surface groups and a
benzyloxycarbonyl (Cbz) protected core were synthesised and characterised using the
same methods that were used to prepare dendrons reported in publication I. The
photolabile o-nitrobenzyl linking group (pll) was first connected with a peptide bond to
spermine 1, which had been appropriately protected with Boc protecting groups. The pll-
spermine conjugate was subsequently coupled with the trifurcated Newkome-type
branching scaffold 6 by simple esterification reaction. Standard catalyst agents and
refluxing solvent were needed to form the product 18. Crude materials were purified by
using preparative GPC and silica column. Deprotection of the spermine groups using HCl
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yielded highly water-soluble target dendrons pll-G1 and pll-G2. The second generation
dendron was synthesised in a analogous manner by esterification of pll-spermine 17 to
G2-acid 9. Model compound pll-G0 was obtained directly from pll-spermine conjugate
17.
Figure 19. Spermine derivatives. a) Target photolabile dendrons pll-G0, pll-G1 and pll-G2. b)
Photolysis of pll-G1 and pll-G2 liberates spermine surface and exposes carboxylic acids. c)
Schematic illustration of the self-assembly of multivalent dendrons and DNA, followed by the
optically triggered degradation of cationic surface and release of DNA. The release is therefore
due to two factors: optically triggered cleavage of the spermine chains and cationic-to-anionic
charge reverse. Blue spheres: photo-cleavage sites, red spheres: cationic spermine amines,
yellow spheres: anionic carboxylic acid groups exposed after photolysis.
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DNA binding affinities of spermine derivatives were evaluated using an ethidium
bromide displacement assay.140 The strengths of the resulting DNA-dendron complexes
were also studied by DNA relaxation using chondroitin sulfate B (csB), which is a sulfated
polyanionic glycosaminoglycan known to effectively relax weak DNA-cation
complexes.141 These results are presented as a function of sulfonic acid /protonatable
dendron amine (S/N) ratio.
Two different salt concentrations (9.4 mM and 150 mM NaCl) at a physiologically
relevant pH value of 7.2 were again studied. Under low-salt conditions (9.4 mM NaCl) the
non-dendritic compounds spermine and pll-G0 bind to DNA, although not particularly
effectively (CE50= 6 and 32 respectively, Figure 20a, Table 3). The dendritic systems pll-
G1 and pll-G2, however, bind DNA very strongly with similar strength (CE50= 0.5 and
0.4 respectively, Figure 20a, Table 3). At high salt concentration (150 mM NaCl) spermine
and pll-G0 almost completely lose their DNA binding ability (CE50 values >200, Figure
20b, Table 3). Conversely, pll-G1 and pll-G2 are only little affected by the increase of
competitive Na+ ions, due to the multivalent nature of these dendritic systems. Larger pll-
G2 binds slightly stronger than pll-G1 (CE50= 0.7 and 1.0 respectively, Figure 20b, Table
3). These CE50 values are in good accordance with, although slightly lower than, the
values for spermine derivatives without pll-linker presented in publication I.142
Complex relaxation with csB at 9.4 mM NaCl salt concentration shows that pll-G0 and
spermine pack DNA into weak complexes, which are easily opened by relatively small
amount of csB (Figure 20c). However, pll-G1 and pll-G2 form extremely strong
complexes with DNA and can not be opened even with very high S/N ratios (Figure 20c).
When the salt concentration is increased to 150 mM, the complexes are slightly weaker,
and it is possible to open them. The pll-G1??DNA complex can be fully relaxed with an
approximately ten-fold excess of csB, whereas pll-G2 complexes are stronger and are
relaxed at 50-fold excess (Figure 20d).
28
0
20
40
60
80
100
0 50 100 150
UV exposure (s)
F rel. I
(%)
G1
pll-G1
pll-G2
0
20
40
60
80
100
0 50 100 150
UV exposure (s)
F rel. I
(%)
G1
pll-G1
pll-G2
0
20
40
60
80
100
0.1 1 10 100 1000
CE
F rel. I
(%)
spermine pll-G0
pll-G1
pll-G2
0
20
40
60
80
100
0.1 1 10 100 1000
CE
F rel. I
(%)
spermine
pll-G0
pll-G1
pll-G2
0
20
40
60
80
100
0.001 0.01 0.1 1 10 100 1000
S/N
F rel. I
(%)
pll-G1
pll-G2
0
20
40
60
80
100
0.001 0.01 0.1 1 10 100 1000
S/N
F rel. I
(%)
pll-G0
p ll-G1
pll-G2
spe rmin e
a)
b) d) f)
c) e)
Figure 20. Titration curves for spermine, pll-G0, pll-G1 or pll-G2. EthBr fluorescence
quenching in the presence a) 9.4 mM and b) 150 mM NaCl. DNA-polycation complex
relaxation with csB in the presence of c) 9.4 mM and d) 150 mM NaCl. Release of DNA from
complexes by UV irradiation in the presence of e) 9.4 mM and f) 150 mM NaCl. Total added
polyamine solution did not exceed 5% of the total volume; therefore corrections were not made
for sample dilution. Results are the average of triplicates, error bars ± standard deviation.
Table 3. Results for spermine pll-G0, pll-G1 and pll-G2 from an ethidium bromide
displacement assay.
Compound Nominal charge CE50 / 9.4mM NaCl
CE50 / 150
mM NaCl
spermine 4+ 6 >400
pll-G0 3+ 32 >200
pll-G1 9+ 0.5 1.0
pll-G2 27+ 0.4 0.7
The photolytic degradation of the spermine derivatives was first studied as such,
without any DNA present. Degradation was attained by irradiating an aqueous solution of
pll-G2 (Figure 21) and following the time-course of the reaction with UV-Vis
spectroscopy. Irradiation of pll-G2 compounds with UV light at 350 nm led to significant
changes in the UV-Vis spectra. A decrease of absorbance at 245 nm was observed along
with a clear increase at 268 nm and 349 nm? ? changes which typically indicate the
photolytic reaction proposed in Figure 19b.129, 136 Similar changes were observed also for
pll-G0 and pll-G1. Figure 21b shows that degradation of the dendritic systems reaches a
plateau after ca. 200 s and pll-G2 releases approximately three times more surface groups
than pll-G1, which in turn releases three times more surface groups than pll-G0. This
9:3:1 ratio is consistent with the number of surface groups in pll-G2, pll-G1 and pll-G0
respectively. Longer irradiation times lead to further changes in the absorption spectra, for
example decrease of absorption at 330-400 nm.134
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Figure 21. Photolysis of spermine derivatives. a) UV-Vis spectra of pll-G2 after different
irradiation times (0-260 s) with UV light. b) Molar absorption coefficient of pll-G0, pll-G1 and
pll-G2 at 390 nm plotted against UV irradiation time indicate that the photochemical reaction
takes place and pll-G2 releases approximately three times more surface groups than pll-G1.
Dendron-DNA complex disassembly was then directly monitored as a function of UV
irradiation time by using the ethidium bromide displacement assay. DNA was first fully
complexed with the dendritic polycation (CE=2) and the resulting complexes were
irradiated under UV light. EthBr fluorescence was then recorded after different time
periods ? if dendron disassembly occurs, the EthBr should be able to compete effectively
for DNA binding with the resulting individual spermine units, and hence the fluorescence
intensity of EthBr should increase. At 9.4 mM NaCl concentration EthBr fluorescence
increases, indicating that both pll-dendrons release DNA after 90 s (Figure 20e). At 150
mM salt concentration pll-G1 releases DNA rapidly after 40 s and pll-G2 after 55 s
(Figure 20f). This more rapid release might be expected as a result of the slightly weaker
complexation between the dendron and DNA under the high salt conditions (particularly
for pll-G1). Dendron G1 (pll-G1 without the photolabile o-nitrobenzyl linker, see
publication I) was used as a reference under both salt concentrations and markedly no
release of DNA from these complexes was observed as a result of UV irradiation.
Importantly, the same trend, that at 9.4 mM NaCl concentration pll-G1 and pll-G2 behave
similarly while at 150 mM NaCl concentration pll-G2 binds DNA more strongly than pll-
G1, is consistent across all three fluorescence titration methods.
DNA binding and release by pll-dendrons was confirmed by gel electrophoresis in a
direct plasmid DNA (pDNA) binding assay. The photolabile dendritic constructs pll-G1
and pll-G2 retarded the electrophoretic mobility of DNA, whilst pll-G0 was ineffective
(Figure 22). After UV irradiation, pll-G1 and pll-G2 clearly released DNA, allowing its
free electrophoretic mobility. Importantly, UV irradiation induced pDNA fragmentation
was not observed, indicating that the structure and functionality of the pDNA is preserved
under these conditions.
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Figure 22. Gel electrophoresis of pDNA (250 ng per lane). Lane 1: pDNA. Lane 2: pDNA + pll-
G0 (CE 30) no UV. Lane 3: pDNA + pll-G1 (CE 2) no UV. Lane 4: pDNA + pll-G2 (CE 2) no
UV. Lane 5: pDNA + pll-G1 (CE 2) 1 min UV. Lane 6: pDNA + pll-G2 (CE 2) 1 min UV. Lane
7: pDNA 1 min UV.
Light scattering and -potential measurements studies were used to further investigate
the DNA binding and releasing properties of the dendritic molecules in addition to the
surface charge of the formed DNA complexes. DNA was complexed with pll-G2 or pll-
G1 with CE 2 and the particle count-rate and -potential were measured before and after
one minute of UV irradiation. Before UV treatment, the observed count-rate for pll-G2 ?
DNA complex was 420.9 kilo counts per second (kcps) and -potential 14.7±3.4 mV,
indicating the formation of a large number of positively charged particles. After UV
irradiation, however, the particle count rate was found to drop off to only 8.8 kcps and the
-potential to 27.8±7 mV. This confirms the complex breakdown and the formation of
species with a high anionic charge. The decrease in the count rate is attributed to the
change in the refractive index of the dendron-DNA complexes as they undergo a transition
from condensed globules to loose coils, which have a lower refractive index than dense
globules. Similar behaviour was observed also by using pll-G1 as the binding agent.
Summary of the light scattering and the -potential results is presented in Table 4.
Table 4. Light scattering and the -potential measurement results.
before UV-irradiation after 1 min UV irradiation
compound count rate (kcps) -potential count rate (kcps) -potential
pll-G1 380.7 18±5.8 7.9 (19.1±4.5)
pll-G2 420.9 14.7±3.4 8.8 (27.8±7)
In conclusion, our novel photolabile multivalent dendrons can be used for reversible
DNA binding. DNA release is made possible by long-wavelength UV irradiation ( =350
nm), which cleaves the surface groups from the dendron framework and therefore
degrades and charge reverses dendron?s multivalency. In particular, pll-G1 and pll-G2
bind DNA efficiently through complementary electrostatic interactions, but can also
release their target very rapidly. Effectively, the high-affinity multivalent interactions are
?switched-off? by UV irradiation. It is therefore possible to gain spatio-temporal control
over DNA binding and release, making these dendrons very promising for detailed
applications in nanobiotechnology.
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3. HIGH AFFINITY ADHESION OF PROTEINS TO DNA
Nature has evolved a vast repository of proteins and enzymes to carry out a wide range
of sophisticated tasks, which have been extensively exploited by biotechnology and
medicine.143 Such properties are, however, only as good as conferred by nature, and
efforts to improve or to alter the biological properties of proteins have been made in
various ways.144 One of these methods is to modify the protein by attaching a polymer
chain covalently onto its surface.126 Examples of such modifications have yielded high-
affinity binding to biomolecules, tissue or intracellular targeting by multivalent binding to
cell surface receptors,145 prolonged circulation lifetime,146-150 thermal switching of enzyme
activity,151 and size-dependent binding.152 However, approaches that would mimic the
DNA binding properties of natural proteins153 have previously received little attention.
DNA binding and transfection ability of polyamine dendrons was studied and
demonstrated in articles I-III. In this chapter, the data of the last two publications (IV and
V) is presented, where we describe how the dendrons can be attached onto protein
surfaces and how they function. It is demonstrated that the DNA binding ability of the
dendrons can change the biological properties of proteins, enabling them to self-assemble
with DNA.
3.1. Synthesis of Protein-Dendron Conjugates for DNA Binding
(Articles IV and V)
Methods to prepare well-defined protein-polymer conjugates144, 146, 154-156 can be
divided into two different classes: ?grafting to?157-161 and ?grafting from162-164: The former
way utilises a protein-reactive polymer, which can be attached onto reactive groups on
protein surface and the latter initiation sites attached on the protein surface where
polymerisation can take place directly. Alternatively modification can be achieved by
cofactor reconstitution.165-167 Most studies concentrate on linear polymers, but a drawback
to their use is that they induce a degree of heterogeneity in the form of both the attached
polymer and often the protein attachment sites. Dendrons, however, are not afflicted by
these problems. Conversely, only relatively few studies on protein-dendron conjugates
exist, including for example, protein with dendritic bisphosphonic acid,168 anionic
myoglobin derivatives,159, 166, 167 dendrons with multiple proteins on surface,169 synthetic
glycoproteins170, insulin modified with sialic acid171 and PAMAM-biotin conjugates.172
We chose to use the maleimido chemistry to target a single free cysteine residue on
protein surface. N-maleimido group is well known to react very selectively with free
sulfhydryl groups in neutral aqueous solutions and ambient temperature. N-maleimido
cored first and second generation dendrons were prepared from the synthesis intermediates
7 and 10, used in the preparation of polyamine dendrons presented in publication I.
Deprotection of the Cbz-protected amino core using catalytic hydrogenation yielded the
free amines at the focal point (compounds 11 and 14), which were subsequently reacted
with an excess of 3-maleimidopropionic acid to afford cysteine reactive dendrons 12 and
15. Deprotection of the spermine groups using HCl then yielded highly water-soluble
target dendrons 13 and 16 with an intact N-maleimido group at the core. However it is
noteworthy that while the synthesis of dendrons might seem to be a simple process, it is
still relatively difficult to produce bulk quantities of high generation dendrimers, because
of the multiple synthesis and purification steps.
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Ideal proteins for precise conjugation should contain only one reactive sulfhydryl
group, although methods to modify native disulfide-bridged cysteines using a thiol-
specific, cross-functionalised monosulfone have also been studied.173-175 Precise
conjugation is essential if the protein functionality is to preserved; conjugation of a large
molecule too close to proteins active part could alter or hamper its functionality
dramatically. Free cysteines that are reactive because they do not take part in disulfide
bridge formation are rare in proteins: for example a globular Bovine Serum Albumin
(BSA) contains naturally only one reactive cysteine (Cys-34). Furthermore, approximately
50% of these cysteine residues are oxidised and thus unavailable for conjugation.176
Nonetheless, BSA was chosen as our large (66.4 kDa, 607 amino acids) model protein.
Serum albumin is the most abundant plasma protein in mammals and functions as non-
specific carrier for several hydrophobic compounds such as fatty acids and steroid
hormones, carrier for unconjugated bilirubin and calcium ion binder. It also partly
maintains the osmotic pressure in blood plasma by preventing water from crossing
capillary walls into tissue. BSA structure consists of three homologous looping domains
held together by 17 disulphide bonds (Figure 23). Domain structures are highly alpha-
helical and lack beta-sheets. BSA is readily available commercially and exhibits other
potential advantages, such as long circulation time and low toxicity. Indeed, a commercial
drug formulation Abraxane incorporates albumin to improve the solubility and reduce the
toxicity of paclitaxel.177
Class II hydrophobin (HFBI) from Trichoderma reesei178-183 was chosen as another
protein for the protein-dendron conjugation reactions.184 In common globular proteins the
hydrophobic residues are buried inside the protein, but HFBI has a very unusual
amphiphilic structure where approximately half of its hydrophobic amino acid side chains
form a hydrophobic patch exposed to the protein surface. HFBI can therefore be regarded
as a mesoscale surfactant protein. Mesoscale surfactants are thought to have very
interesting properties in hydrophobic assembly.185, 186 The HFBI fold forms two -harpins
linked by a short alpha-helix resulting in an antiparallel -barrel structure (Figure 23). The
-barrel is further stabilised by four cross linking disulfide bridges, which are buried
inside the protein and make the fold very compact and relatively hard to denaturate. Due
to its surface activity, HFBI is known to form various structures through spontaneous self-
assemby. Indeed hydrophobin films with a self-assembled hexagonally ordered structure
are now well characterised.187-189 The natural structure of HFBI does not provide a single
free cysteine residue, therefore site-directed mutagenesis was used to construct a protein
variant of HFBI with a free sulfhydryl group for site-specific conjugation. The protein
variant, termed NCys-HFBI, was produced in its homologous production host
Trichoderma reesei and purified from the fermentation biomass yielding partially oxidised
covalent dimer of NCys-HFBI.179 After purification, disulfide bridged NCys-HFBI dimers
were reduced to monomers (HFBI) with dithiothreitol.
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Figure 23. Structure of HFBI (left) and BSA (right). The conserved side chains of the
hydrophobic patch of HFBI are shown in red.
The reduced HFBI was conjugated to the first and second generation dendrons in
buffered aqueous solution at neutral pH using an excess of dendron (Figure 24).
Conjugation to BSA was done with similar procedure, however BSA was not reacted with
dithiothreitol prior to conjugation. To avoid confusion, it must be noted that BSA contains
a 24 amino acid signal and propeptide sequence not observed in the final translated and
transported protein but is present in the gene. Therefore the free cysteine is the 58th amino
acid in the sequences found from databases. The 1,4-conjugate addition reaction between
N-maleimido group and free cysteine sulfhydryl group was allowed to proceed at least
overnight to ensure maximal conversion.
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Figure 24. Target dendrons for protein modification (13 and 16) and preparation of protein-
dendron conjugates (BSA-G1, BSA-G2, HFBI-G1 and HFBI-G2). Reaction conditions: H2O,
pH 7.
Analytical data for BSA, HFBI and the protein dendron conjugates is presented in
Figure 25 and Table 5. Purification by semi-preparative HPLC allowed the separation of
free protein form the protein dendron conjugates. Separation efficiency was less effective
for BSA conjugates than for HFBI conjugates, probably because the attached dendron
does not alter the retention of a large hydrophilic protein as much as a small amphiphilic
one. Even so, the separation efficiency was enough to recover pure material in all cases.
Peaks were fractionated, pooled and finally lyophilised to yield the products as white
solids. High purity after pooling was confirmed by analytical HPLC, which shows a single
symmetric peak for all purified compounds. The elution times within the protein series
gradually decrease as the growing size of the dendron increases water solubility and
therefore hinders retention. For both proteins smaller retention volume was observed with
dendron attachment and increasing dendritic generation as would be expected because of
the high hydrophilicity of the dendrons. Overall larger retention volume of HFBI
conjugates is consistent with their higher hydrophobicity when compared to BSA
conjugates. Analysis by matrix-assisted laser desorption ionisation ? time of flight
(MALDI-TOF) mass spectrometry shows clear signals with good accordance to the
calculated mass of the conjugates, confirming the covalent structure of the target
molecules (Table 5, Figure 25b). CD measurements were used to confirm that the protein
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structure is not detectably changed by the attached dendron (Figure 25c). CD spectra for
BSA based compounds are consistent with the high content of helical secondary structure.
The spectra for HFBI and its conjugates indicate rich random coil and -sheet content,
also consistent with the protein native structure. Details of the analytical data are presented
in Table 5. The results show that this is a convenient method to prepare exact one-to-one
protein-dendron conjugates in good yield (~80% for HFBI and ~50% for BSA) and could
also be applicable to other functionalised dendrons.
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Figure 25. Analytical data for protein-dendron conjugates. a) Analytical HPLC chromatogram
of the purified BSA, BSA-G1 and BSA-G2 showing a decreasing retention volume with
increasing dendritic generation, see Table 5 for values. b) MALDI-TOF spectra of purified
BSA, BSA-G1 and BSA-G2 showing increasing mass with increasing dendritic generation, see
Table 5 for values. c) CD-spectra for all studied proteins and their dendron conjugates
confirming that the protein structure is not detectably changed by the attached dendron. A
schematic computer generated model of d) BSA-G1 and e) BSA-G2. Cys-34 and the attached
dendron are shown in red.
Table 5. Analytical data for protein-dendron conjugates.
Compound Calc. mass /g mol-1
MALDI-
TOF / m z-1
Retention volume /
mL (semi-
preparative HPLC)
Conjugation
yield (%)[a]
Retention volume /
mL (analytical
HPLC)
BSA 66 430.3[190 66 444.3 76.96 - 20.33
BSA-G1 67 471.7 67 404.1 75.70 53 20.00
BSA-G2 69 535.6 69 552.5 72.71 48 19.82
HFBI 8 676.7 8 676.5 107.45 - 23.86
HFBI-G1 9 718.1 9 722.4 98.49 79 22.87
HFBI-G2 11 782.0 11 782.8 91.97 83 21.13
[a] Approximated from peak heights (semi-preparative HPLC).
In summary, we have described N-maleimido cored dendrons that selectively react via
1,4-conjugate addition with a single free thiol group on the protein surface ? Cys-34 of
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3.2. Functionality of Protein-Dendron conjugates (Articles IV and V)
nt
er
to
h ment assay both unmodified proteins, BSA and HFBI, were
 t is was expected as commonly proteins that do not have DNA
bin
vine Serum Albumin (BSA) or genetically engineered cysteine mutant of Class II
hydrophobin (HFBI). Because the location of the thiol group is known exactly, the
resulting one-to-one protein-polymer conjugates are extremely well defined ? the number
of dendrons and their attachment site on the protein surface is precisely known. The
conjugation reaction can be conducted in mild aqueous solutions (pH 7.2-7.4) and ambient
temperature resulting in BSA and HFBI-dendron conjugates in yields of at least 48% and
79% respectively.
After establishing robust synthetic and purification methods to prepare sufficie
amounts of protein-dendron conjugates, a series of different methods were utilised in ord
asses the various functional properties of the protein dendron conjugates.
3.2.1. DNA Binding
In t e EthBr displace
unable o bind DNA. Th
ding motifs or significant surface positive charge do not bind DNA. No interaction
with DNA was observed even with high protein concentrations (Figure 26a,d, Table 6).
However, the protein-dendron conjugates showed significantly enhanced DNA binding.
Under low-salt conditions (9.4 mM NaCl) HFBI-G1 and HFBI-G2 bind DNA very
strongly and with similar affinity (CE50=0.6, Figure 26d, Table 6). BSA-G2 also binds
strongly, however with slightly lower affinity (CE50=1.0, Figure 26a, Table 6). BSA-G1
exhibits lower binding affinity (CE50= 3.5, Figure 26a, Table 6) when compared to other
protein-dendron conjugates. The lower binding affinity for this dendron conjugated BSA
might be expected because the rather small dendron (ca. 1 kDa) must adhere a much larger
BSA protein (ca. 66 kDa) to DNA. At physiological salt concentration (150 mM) BSA-G1
and HFBI-G1 both exhibit weaker binding than at low salt concentration (CE50=6.3 and
0.9 respectively, Figure 26b,e, Table 6). The binding affinity of BSA-G1 is affected the
most. It also interesting to notice that BSA-G1 binds DNA with noticeably lower affinity
than G1 (see publication I) alone ? this is presumably a consequence of the entropic cost
of binding the high molecular mass BSA protein to the DNA. Nonetheless, the measured
binding value is surprisingly strong. On the contrary BSA-G2 and HFBI-G2 are little
affected by the increase in salt concentration and they bind DNA with extremely strong
affinities (CE50=0.6 and 0.5 respectively, Figure 26b,e, Table 6) as a consequence of their
multivalent nature.
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Figure 26. Ethidium bromide displacement assay curves for spermine, BSA, BSA-G1, BSA-
G2, HFBI, HFBI-G1 or HFBI-G2 in a solution of 1 M DNA and 1.26 M ethidium bromide
in buffered water (pH 7.2). EthBr fluorescence quenching in the presence a,d) 9.4 mM and b,e)
150 mM NaCl. DNA-polycation complex relaxation with csB in the presence of c,f) 150 mM
NaCl. Results are the average of triplicates, error bars ± standard deviation.
Complex strength evaluation using csB as relaxing agent shows that BSA-G2 packs
DNA into a strong complex, which can be fully opened only with an excess of csB (S/N
ratio >25, Figure 26c). Complexes formed with BSA-G1 are significantly weaker and can
be opened with relatively small S/N ratio (S/N ratio ca. 5, Figure 26c). Smaller HFBI-
dendron conjugates are able to pack DNA even more strongly when compared to BSA
conjugates. Both HFBI-G1 and HFBI-G2 pack DNA into strong complexes with similar
strength. Both complexes can only be fully relaxed at S/N ratios of approximately >30
(Figure 26f).
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Table 6. Results for spermine BSA, BSA-G1, BSA-G2, HFBI, HFBI-G1 and HFBI-G2 from
an ethidium bromide displacement assay.[a]
Compound Nominalcharge
Calculated
FW [g/mol]
CE50 / 9.4
mM NaCl
CE50 / 150
mM NaCl
spermine 4+ 362.5 6.0 >400
BSA (9+)[b] 66 430.3190 >400 >400
BSA-G1 9+ 67471.7 3.5 6.3
BSA-G2 27+ 69 535.6 1.0 0.6
HFBI (4+)[c] 8676.7 >200 >200
HFBI-G1 9+ 9718.1 0.6 0.9
HFBI-G2 27+ 11782.0 0.6 0.5
[a] Total added polyamine solution did not exceed 5% of the total volume; therefore corrections
were not made for sample dilution. Results are an average of three titrations. [b] BSA has an
overall negative surface charge (pI<6) at neutral pH, however nine positive charges were
assumed for comparison. [c] According to protein amino acid sequence and the number of
protonable side chains, four positive charges were assumed.
Taken the results together, they demonstrate that a functional DNA binding dendron
can impart its properties onto the protein to which it is attached. This method enables us to
convey DNA affinity to proteins that do not have a natural DNA binding affinity. The
binding values measured for the protein-dendron conjugates are, especially for BSA
conjugates, surprisingly strong and in general agreement with those measured for the
dendrons alone (see publication I). The binding affinity of BSA-G1 is relatively strong
and shows that even a rather small (ca. 1 kDa) G1 dendron can convey reasonable binding
affinity even to a much larger protein (ca. 66 kDa). This kind of behavior much resembles
the binding of natural proteins that rely on DNA binding domains.153 Dendrons attached to
the protein surface can therefore be described as synthetic DNA binding domains.
3.2.2. Surface Self-Assembly
The amphiphilicity of the HFBI-dendron conjugates was first studied on solid surface.
Considering the possible applications of these conjugates in gene therapy, the
hydrophobicity of the carrier is known to strongly influence the DNA transport through
cellular membranes into cells107 and is therefore important to characterise. Quartz crystal
microbalance (QCM) was used to study the surface adhesion and binding properties of
HFBI-dendron conjugates. QCM can measure small changes in mass on a quartz crystal
resonator in real-time. During measurement two types of information are given. The
change in crystal?s resonance frequency ( f) is directly proportional to the absorbed mass
on the crystal, and the dissipation (D) change gives information about the decay of the
resonance signal, which is dependent on the structure of the absorbed layer. Usually high
dissipation energy indicates flexible or loose structure.
One of the remarkable properties of hydrophobins is their ability to form self-
assembled films on hydrophobic surfaces or air-water interface.187, 191 These features have
been demonstrated previously for various different types of hydrophobins,191 however we
wanted to demonstrate the same effect also with protein-dendron conjugates. The HFBI
and HFBI-G2 were immobilised on hydrophobic polystyrene coated crystals. Figure 27
shows the adsorbtion of both compounds at concentration of 50 g/mL. Both compounds
adsorb rapidly in a similar manner, reaching the maximum level almost instantly, as would
be expected for amphiphilic proteins. However, HFBI-G2 induces larger dissipation
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compared to HFBI alone and is attributed to the fact that the flexible second generation
dendron attached to the protein induces flexibility also to the conjugate (Figure 27).
Washing with buffered water did not reduce the amount of surface bound compounds.
After immobilisation and washing of the functionalised sensor crystals, their interaction
with DNA was examined. DNA was injected in the same buffer system at 0.2 mM
nucleotide concentration. As expected, HFBI does not show any interaction with DNA
seeing that no shift in frequency or dissipation energy was observed. HFBI-G2, however,
showed a clear shift in frequency, indicating DNA binding. Also the clear reduction in
dissipation energy indicates that the dendron becomes more rigid as a result of DNA
binding along the surface.
Figure 27. Surface adhesion and DNA binding properties of HFBI and HFBI-G2 as measured
by the change in resonance frequency (a) and dissipation energy (b). HFBI or HFBI-G2 was
added after 3 min, DNA was added after 16 min.
The surface-activities of HFBI-G1 and HFBI-G2 on air water interface were studied
by compressing Langmuir films (Figure 28a). The unmodified HFBI isotherm shows a
steep liquid-condensed behaviour and a collapse at ca. 35 mN/m. HFBI-G1 shows a rapid
rise of the surface pressure at mean molecular area (Mma) ca. 60 Å2 and a collapse point
at 60 mN/m, whereas measured Mma value of HFBI-G2 is shifted even lower to ca. 10 Å2
and a collapse point at 56 mN/m. These results further verify the amphiphilicity of the
HFBI-conjugates and agreeably show dendritic effect to the film formation, where
increasing the dendritic generation on the protein surface makes it more soluble in the
subphase and therefore sifts the Mma to lower Å2 values because an increasing amount of
the material is lost into the subphase.
Atomic force microscope (AFM) was used to directly image and assess the crystallinity
of the protein-dendron conjugate films. The films were prepared using a Langmuir trough
compression and then deposited onto a graphite substrate, after which they were dried and
imaged with AFM. The AFM images reveal that dendron modified hydrophobins can form
stable films on air-water interface and that the films have a regular hexagonal-like
structure with the dimension of a few nanometers (Figure 28b,c). The same kind of
structure was observed for both HFBI-G1 and HFBI-G2 films. Analysing the structured
parts of the surfaces using Fourier transform yielded 2D crystal unit cells of a=5.9 nm,
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b=5.4 nm, =119° for HFBI-G1 and a=5.3, b=4.9, =115° for HFBI-G2, indicating a
close to hexagonal packing in both cases (Figure 28b,c inset).
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Figure 28. a) Surface pressure - area isotherms obtained by compressing HFBI-G1 or HFBI-
G2 Langmuir films. The HFBI isotherm is plotted as a reference. b,c) Correlation averaged
AFM topography image of b) HFBI-G1 and c) HFBI-G2 Langmuir film showing a regular
ordered hexagonal patterns of objects. Image size is 19 nm x 19 nm. Insets: Fast Fourier
transforms of single crystalline areas of HFBI-G1 or HFBI-G2 film.
In summary, these results demonstrate that HFBI-dendron conjugates can adhere on
hydrophobic surfaces and bind DNA. Behaviour of the conjugates on air-water interface
show how the surface-activity of the HFBI-dendron conjugates is dependent on the
attached dendron. In addition, AFM images confirm that the conjugates can self-assemble
into a similar hexagonal array as HFBI alone.
3.2.3. Cytotoxicity and gene transfection
Cytotoxicity is an important feature in non-viral gene therapy, as ideal vectors should
exhibit low or nonexistent toxicity. Proteins have diverse effects on cellular metabolism,
however for example HFBI and BSA in particular are well known for their safety.
Polycationic compounds, however, are known to damage cell membranes as a result of
their electrostatic interactions with the plasma membrane.132 With this potential drawback
in mind, cytotoxicity of our protein-dendron conjugates towards fibroblasts cells (CV1-P)
was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. None of the studied compounds showed any toxicity at CE ratios 0.125-4.
However, HFBI-G1 and HFBI-G2 were observed to be slightly cytotoxic at high CE
ratios, where relative cell viability decreased markedly (Figure 29a). HFBI did not reduce
cell viability at any CE ratio. At CE 16 HFBI-G1 decreased relative cell viability to ca.
62% and HFBI-G2 to ca 50% (Figure 29a). BSA and its dendron conjugates did not
indicate any toxicity.
Recent studies in protein-polymer conjugates have shown that they can be used as non-
viral vectors in gene therapy. For example conjugates containing a cationic polymer such
as polyethyleneimine (PEI) or poly(L-lysine) and an immunoglobulin, have been
developed.118, 120, 121 In these conjugates the cationic polymer is used to bind and compact
DNA and the antibody being selected to facilitate receptor mediated gene delivery into
various cell types.122 Our approach is similar; the cationic dendron is used to bind DNA
and the protein functionality is used to increase penetration through cellular membranes.
We investigated the protein-dendron conjugate mediated gene delivery into CV1-P cells
41
with varying CE ratios of (Figure 29b). Gene transfection efficiency was measured as -
galactosidase expression. PEI 25k and plain pDNA were used as positive and negative
controls respectively. We observed clearly enhanced transfection only for HFBI-G2 with
high charge excess ratio ( 4), while all the other protein-dendron conjugates were unable
to mediate efficient transfection. Optimal transfection efficiency was achieved at CE 4 and
notably, no cytotoxicity was observed with this CE ratio. We suspect that this increase in
the transfection efficiency is due to the protein amphiphilicity, because the results
presented in Publication II indicated that the dendrons alone are relatively ineffective
transfection agents and BSA and its dendron conjugates did not induce measurable -
galactosidase activity. Clearly this is not due to a weak or different DNA binding
mechanism of BSA-G2, because both HFBI-G2 and BSA-G2 bind DNA in a similar
manner. However, higher surface-activity does not alone increase transfection because
HFBI-G1 is not efficient even though it is more surface-active than HFBI-G2. There have
been no previous studies on the interactions between hydrophobins and biological
membranes, but the current results indicate that these interactions would make an
interesting future study.
Taken the results together, we have demonstrated that HFBI modified with a DNA
binding dendron, functions as a cationic surfactant capable of delivering DNA across
biological membrane and is not markedly cytotoxic at low CE ratios. It must be noted that
the overall transfection efficiency of HFBI-G2 is low when compared to PEI 25k, which
induced over 20-fold higher -galactosidase activity. However, this is significantly better
than the previously reported behavior of simple G2 dendron as a transfection agent (see
Publication II).
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Figure 29. a) Cytotoxicity of HFBI, HFBI-G1, HFBI-G2 and PEI 25k in kidney fibroblast
cells (CV1-P) reported as relative cell viability (%). b) Transfection efficiency of HFBI,
HFBI-G1 or HFBI-G2 in CV1-P cells given as mU of -galactosidase activity. Results are the
average of triplicates, error bars represent the standard deviation.
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4. CONCLUSION
This Thesis presents novel dendritic derivatives for high-affinity DNA binding. The
dendrons consist of Newkome-type polyether framework and multiple spermine units,
nature’s own DNA binder, on the surface of a dendritic scaffold. The dendrons interact
with DNA in generation dependent (G2>G1>G0) manner with the more highly branched
dendrons being the strongest DNA binders probably due to the chelate and statistical
effect of multivalency (Figure 5, page 8). Importantly, the linear G0 analogue was unable
to bind DNA at physiological salt concentration.
Gene transfection efficiency of these dendrons remained very poor, even when
administrated with chloroquine, which assists escape from endocytic vesicles. One
possible reason for low transfection efficiency is that the interaction between the dendron
and the DNA is in fact too strong and therefore DNA is not released. The dendrons,
however, were not markedly toxic either alone or in the presence of DNA.
In order to address the DNA release problem, optically triggered release of DNA from
the dendrons was made possible by attaching the surface spermine groups by o-
nitrobenzyl to dendron frame. Upon photolysis the surface groups are cleaved leaving
behind an anionic carboxylic acid surface and only individual spermine groups, which
were previously found not to be able to bind DNA. Due to this degradation and charge
switching of multivalency, the DNA is rapidly released.
DNA binding dendrons can also be attached onto protein surfaces by employing
maleimido chemistry to yield precisely defined protein-polymer conjugates where the
number of dendrons and their attachment site are precisely known. It is therefore possible
to convey DNA affinity to proteins that do not have natural DNA binding ability.
Importantly the DNA binding ability of the second generation dendron is not affected even
when it is bound on the surface of a large biomolecule. The protein part in the conjugate
can also play an active role by for example promoting surface adhesion or transfection
efficiency.
We expect that the functional dendrons and the union between proteins and multivalent
synthetic compounds open a route to novel applications in gene protection and delivery. It
is further possible to ‘fine-tune’ the functionality of the dendron periphery by means of
organic synthesis and to further control the interactions between molecules and the self-
assembly of nanoscale bioconjugates in more general way.
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ABSTRACTS OF PUBLICATIONS I-V
I. High-affinity binding between nanoscale objects is an essential prerequisite for
?bottom-up? fabrication. In recent years, interest has focused on the use of
dendritic macromolecules as supramolecular nanoscale building blocks. The
branched superstructure of dendrons and dendrimers offers specific advantages,
for example, enhancement of weak binding by using multivalent arrays of
recognition units on the dendritic surface. This multivalency principle, in which
organized arrays amplify the strength of a weak binding process, such as the
binding of saccharides to proteins on cell surfaces, is now well established. We
are interested in optimising DNA binding and developing low-molecular-mass
dendrons with very high affinities for DNA?such systems are particularly useful
for DNA encapsulation and protection. Herein, we report on multivalent dendritic
spermine constructs with well-defined molecular structures and extremely high,
salt-independent binding affinities for DNA. These monodisperse systems enable
an understanding of structure?activity relationships and, in addition, have a
greater chance of being licensed for therapeutic applications in the longer term.
II. This paper investigates a series of dendrons based on the Newkome dendritic
scaffold that displays a naturally occurring polyamine (spermine) on their surface.
These dendrons have previously been shown to interact with DNA in a generation
dependent manner with the more highly branched dendrons exhibiting a strong
multivalency effect for the spermine surface groups. In this paper, we investigate
the ability of these dendrons to transfect DNA into cells (human breast carcinoma
cells, MDA-MB-231, and murine myoblast cells, C2C12) as determined by the
luciferase assay. Although the dendrons are unable to transfect DNA in their own
right, they are capable of delivering DNA in vitro when administered with
chloroquine, which assists with escape from endocytic vesicles. The cytotoxicity
of the dendrons was determined using the XTT assay, and it was shown that the
dendrons were nontoxic either alone or in the presence of DNA. However, when
administered with DNA and chloroquine, the most highly branched dendron did
exhibit some cytotoxicity. This paper elucidates the relationship between in vitro
transfection efficiency and toxicity. While transfection efficiencies are modest,
the low toxicity of the dendrons, both in their own right, and in the presence of
DNA, provides encouragement that this type of building block, which has a
relatively high affinity for DNA, will provide a useful starting point for the
further synthetic development of more effective gene transfection agents.
III. Multivalent binding between nanoscale objects has recently emerged as one of the
most powerful methodologies for the assembly of functional supramolecular
materials with applications in nanotechnology. Controlling the self-assembly of
nanoscale objects using external stimuli, such as pH, temperature, light, electric
potential, or magnetic field, is an important requirement for the preparation of
functional and responsive molecular machines for a wide range of potential
applications. Here we report cationic multivalent dendrons, with o-nitrobenzyl
linked spermine surface groups that self-assemble with DNA via multivalent ionic
interactions. Cleavage of o-nitrobenzyl groups from the dendron framework by
optical irradiation results in rapid release of the covalently bound surface groups
and non-covalently bound DNA, due to dendron degradation and charge
switching multivalency. These results encourage further developments,
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particularly in controlled gene delivery or spatially and temporally controlled
DNA storage/release systems, which have been proposed to be of relevance in
molecular computing.
IV. Multivalent dendrons that have an N-maleimido group at the focal point can be
used to construct monodisperse one-to-one protein-dendron conjugates. Here we
demonstrate the successful synthesis of series of multivalent protein-dendron
conjugates in which the dendron imparts its properties onto the protein to which it
is attached: i.e. high-affinity DNA binding (as determined by ethidium bromide
fluorescence quenching assay). It is therefore possible to convey DNA affinity to
proteins that do not have natural DNA binding ability. Notably, using this
approach, HFBI-G2 is one of the strongest DNA binding proteins ever reported.
It is further possible to ?fine-tune? the functionality of the dendron periphery by
means of organic synthesis and to further control the interactions between
molecules and the self-assembly of nanoscale bioconjugates.
V. Nature has evolved proteins and enzymes to carry out a wide range of
sophisticated tasks. Proteins modified with functional polymers possess many
desirable physical and chemical properties and have applications in
nanobiotechnology. Here we describe multivalent Newkome-type polyamine
dendrons that function as synthetic DNA-binding domains, which can be
conjugated with proteins. These polyamine dendrons employ naturally occurring
spermine surface groups to bind DNA with high-affinity and are attached onto
protein surfaces in a site-specific manner to yield well-defined one-to-one
protein-polymer conjugates, where the number of dendrons and their attachment
site on the protein surface is precisely known. This precise structure is achieved
by using N-maleimido-cored dendrons that selectively react via 1,4-conjugate
addition with a single free thiol group on the protein surface ? either Cys-34 of
Bovine Serum Albumin (BSA), or a genetically engineered cysteine mutant of
Class II hydrophobin (HFBI). This reaction can be conducted in mild aqueous
solutions (pH 7.2-7.4) and ambient temperature resulting in BSA and HFBI-
dendron conjugates. The protein-dendron conjugates constitute a specific
biosynthetic diblock copolymer and bind DNA with high affinity as shown by
ethidium bromide displacement assay. Importantly, even the low-molecular-
weight first generation polyamine dendron (1 kDa) can bind a large BSA protein
(66.4 kDa) to DNA with relatively good affinity. Preliminary gene transfection,
cytotoxicity and self-assembly studies establish the relevance of this methodology
for in-vitro applications, such as gene therapy and surface patterning. These
results encourage further developments in protein-dendron block copolymer-like
conjugates and will allow the advance of functional biomimetic nanoscale
materials.
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